Related Experiment Video
Updated: Jul 27, 2025

06:15
A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
Published on: July 10, 2017
12.9K
The acromegaly treatment satisfaction questionnaire (Acro-TSQ): turkish adaptation, validity, and reliability study
Mehmet Sözen1, Özlem Köse2, Berrin Çetinarslan3
1Department of Endocrinology and Metabolism, Pituitary Research Center, Kocaeli University Faculty of Medicine, Kocaeli, Turkey. mehmetsozen07@gmail.com.
Pituitary
|June 9, 2023
Summary
This study validated the Turkish version of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) for patients with acromegaly. The Acro-TSQ is a reliable tool for assessing patient-reported outcomes in the Turkish population.
Area of Science:
- Endocrinology
- Patient-Reported Outcomes
- Psychometrics
Background:
- Patient-reported outcomes (PROs) are crucial for evaluating patient perceptions and informing treatment strategies.
- Acromegaly treatment satisfaction is a key aspect of managing this rare endocrine disorder.
Purpose of the Study:
- To adapt and validate the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) for use in the Turkish-speaking population.
- To assess the psychometric properties of the Turkish version of the Acro-TSQ.
Main Methods:
- The Acro-TSQ underwent translation and back-translation.
- 136 patients with acromegaly receiving somatostatin analogue therapy completed the questionnaire via face-to-face interviews.
- Internal consistency, content validity, construct validity, and reliability were evaluated.
Main Results:
- The Turkish Acro-TSQ demonstrated a six-factor structure, explaining 77.2% of the total variance.
- High internal consistency was confirmed with a Cronbach's alpha of 0.870.
- Exploratory and Confirmatory Factor Analyses indicated acceptable fit indices and item loadings, with minor variations from the original scale.
Conclusions:
- The Turkish version of the Acro-TSQ is a valid and reliable patient-reported outcome measure.
- This tool is suitable for assessing treatment satisfaction in Turkish patients with acromegaly.

